Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in Neurology
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Evans, A. H.
Right arrow Articles by Lees, A. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Evans, A. H.
Right arrow Articles by Lees, A. J.
NEUROLOGY 2005;65:1570-1574
© 2005 American Academy of Neurology

Factors influencing susceptibility to compulsive dopaminergic drug use in Parkinson disease

A. H. Evans, A. D. Lawrence, PhD, FRACP, J. Potts, PhD, S. Appel, MD and A. J. Lees, MD, FRCP

From Reta Lila Weston Institute of Neurological Studies and The National Hospital for Neurology and Neurosurgery (A.H. Evans and Drs. Appel and Lees), Queen Square, London; and MRC Cognition and Brain Sciences Unit (Drs. Lawrence and Potts), Cambridge, UK.

Address correspondence and reprint requests to Professor Andrew J. Lees, Reta Lila Weston Institute of Neurological Studies, Windeyer Building, 46 Cleveland Street, London W1T 4JF, UK; e-mail: alees{at}ion.ucl.ac.uk

Background: In the course of treatment, a small group of patients with Parkinson disease (PD) develop a harmful pattern of compulsive dopaminergic drug use, called the dopamine dysregulation syndrome (DDS). Individual factors may influence susceptibility.

Objectives: To identify predisposing factors to DDS in a population of outpatients with PD.

Methods: The authors compared clinical features, impulsive sensation seeking (ISS) personality traits, past experimental drug use, alcohol consumption, smoking behaviors, and depressive symptoms in 25 patients with DDS to an outpatient sample of 100 patients with PD who were not compulsively overusing dopaminergic medication.

Results: Patients with DDS had a significantly younger age at disease onset, higher dopaminergic drug intake, greater past experimental drug use, more depressive symptoms, scored higher on ISS ratings, and tended to have higher alcohol intake. Using logistic regression analysis, we found that novelty seeking personality traits, depressive symptoms, alcohol intake, and age at PD onset were significant predictors of DDS.

Conclusions: These factors may help to identify early patients who are more vulnerable to developing a pattern of compulsive dopaminergic drug use and help minimize its consequences.


Disclosure: The authors report no conflicts of interest.

Received May 23, 2005. Accepted in final form August 1, 2005.


Related articles in Neurology:

November 22 Highlights

Neurology 2005 65: 1518-1519. [Full Text]  



This article has been cited by other articles:


Home page
Arch NeurolHome page
V. Voon and S. H. Fox
Medication-Related Impulse Control and Repetitive Behaviors in Parkinson Disease
Arch Neurol, August 1, 2007; 64(8): 1089 - 1096.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
V. Voon, T. Thomsen, J. M. Miyasaki, M. de Souza, A. Shafro, S. H. Fox, S. Duff-Canning, A. E. Lang, and M. Zurowski
Factors Associated With Dopaminergic Drug-Related Pathological Gambling in Parkinson Disease
Arch Neurol, February 1, 2007; 64(2): 212 - 216.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by AAN Enterprises, Inc.